Intravitreal implant shows potential for treating the root causes of glaucoma and diabetic retinopathy

Published on July 1, 2025
New clinical trials reveal PER-001 as a groundbreaking treatment for glaucoma and diabetic retinopathy, showing significant vision improvements and safety.